Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Cited by (1,019)

Items 801–900 of 1,019

1. Pacemaker and ICD leads: Strategies for long-term management
   Peter Borek, Bruce Larry Wilkoff · 2008 · Journal of Interventional Cardiac Electrophysiology
2. Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
   Marco Metra, Valerio Zacà, Gianfranco Parati, Piergiuseppe Agostoni, Maria Bonadies, Marco Matteo Ciccone, Alessandra Dei, Massimo Iacoviello, Rocco Lagioia, Carolina Lombardi et al. · 2010 · Journal of Cardiovascular Medicine
3. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
   M.D. Cheitlin · 2010 · Yearbook of Cardiology
4. Outcome of Apparently Unexplained Cardiac Arrest
   Adam R.M. Herman, Christopher C. Cheung, Brenda Gerull, Christopher S. Simpson, David H. Birnie, George Joseph Klein, Jean Champagne, Jeff S. Healey, Karen Gibbs, Mario R. Talajic et al. · 2016 · Circulation Arrhythmia and Electrophysiology
5. Exercise Training and Implantable Cardioverter-Defibrillator Shocks in Patients With Heart Failure
   Jonathan Paul Piccini, Anne S. Hellkamp, David J. Whellan, Stephen J. Ellis, Steven J. Keteyian, William E. Kraus, Adrian F. Hernandez, James P. Daubert, Ileana L. Piña, Christopher M. O’Connor · 2013 · JACC Heart Failure
6. Clinical Evaluation of Defibrillation Testing in an Unselected Population of 2,120 Consecutive Patients Undergoing First Implantable Cardioverter-Defibrillator Implant
   Michele Brignole, Eraldo Occhetta, Maria Grazia Bongiorni, Alessandro Proclemer, Stefano Favale, Saverio Iacopino, Leonardo Calò, Antonello Vado, Gianfranco Buja, Giosuè Mascioli et al. · 2012 · Journal of the American College of Cardiology
7. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease
   Paul Khairy · 2016 · Heart
8. Biocompatible and biodegradable triboelectric nanogenerators based on hyaluronic acid hydrogel film
   Hyunki Kim, Saehan Choi, Yunhwa Hong, Jinhyo Chung, Jin Hyeok Choi, Woong-Ku Choi, In Woo Park, Sang Hyeok Park, Hyeok Park, Woo‐Jae Chung et al. · 2020 · Applied Materials Today
9. Psychological Distress and Arrhythmia: Risk Prediction and Potential Modifiers
   Peacock, James, Whang, William · 2013 · Progress in Cardiovascular Diseases
10. Real‐World Data on the Lifespan of Implantable Cardioverter‐Defibrillators Depending on Manufacturers and the Amount of Ventricular Pacing
    Fritz Horlbeck, Fritz Mellert, Jens Kreuz, Georg Nickenig, JOERG OTTO SCHWAB · 2012 · Journal of Cardiovascular Electrophysiology
11. Primary Prevention of Sudden Cardiac Death in a Nonischemic Dilated Cardiomyopathy Population
    Konstantinos A. Gatzoulis, Apostolos-Ilias Vouliotis, Dimitris Tsiachris, Μαρία Σαλούρου, Stefanos Archontakis, Polychronis Dilaveris, Theodoros P. Gialernios, Πέτρος Αρσένος, Georgios Karystinos, Skevos K. Sideris et al. · 2013 · Circulation Arrhythmia and Electrophysiology
12. Are complications of implantable defibrillators under-estimated and benefits over-estimated?
    Michele Brignole · 2009 · EP Europace
13. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation
    Atul Aggarwal, Yongfei Wang, John S. Rumsfeld, Jeptha P. Curtis, Paul A. Heidenreich · 2009 · Heart Rhythm
14. Fluid Status Monitoring with a Wireless Network to Reduce Cardiovascular-Related Hospitalizations and Mortality in Heart Failure: Rationale and Design of the OptiLink HF Study (Optimization of H eart F Ailure Management Using Opti Vol Fluid Status Monitoring and Care Link )
    Johannes Brachmann, Michael Böhm, Karin Rybak, Gunnar G. Klein, Christian Butter, Hanno U. Klemm, Rolf Schomburg, Johannes Siebermair, Carsten Walter Israel, Anil Martin Sinha et al. · 2011 · European Journal of Heart Failure
15. Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation
    Isuru Ranasinghe, Craig S. Parzynski, James V. Freeman, Rachel P. Dreyer, Joseph S. Ross, Joseph G. Akar, Harlan M. Krumholz, Jeptha P. Curtis · 2016 · Annals of Internal Medicine
16. Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Death in Heart Failure
    Lynne Warner Stevenson · 2006 · Circulation
17. Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis
    de Sousa, Marcos R., Morillo, Carlos A., Rabelo, Fábio T., Filho, Antônio M. Nogueira, Ribeiro, Antonio L.P. · 2008 · European Journal of Heart Failure
18. Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: a systematic review and meta-analysis of 39 954 patients
    Ghezzi, Erica S, Sharman, Rhianna L S, Selvanayagam, Joseph B, Psaltis, Peter J, Sanders, Prashanthan, Astley, Jack M, Knayfati, Sara, Batra, Vrinda, Keage, Hannah A D · 2023 · Europace
19. The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis
    Timothy W. Smith, Luc J.L.M. Jordaens, Damj Theuns, Pascal F.H.M. van Dessel, Arthur A.M. Wilde, M. G. Myriam Hunink · 2012 · European Heart Journal
20. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients
    Maully J. Shah, Michael J. Silka, Jennifer N. Avari Silva, Seshadri Balaji, Cheyenne M. Beach, Monica N. Benjamin, Charles I. Berul, Bryan C. Cannon, Frank Cecchin, Mitchell I. Cohen et al. · 2021 · Cardiology in the Young
21. Fighting against sudden cardiac death: need for a paradigm shift—Adding near-term prevention and pre-emptive action to long-term prevention
    Éloi Marijon, Rodrigue Garcia, Kumar Narayanan, Nicole Karam, Xavier Jouven · 2021 · European Heart Journal
22. 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders
    William J. Groh, Deepak Bhakta, Gordon F. Tomaselli, Ryan G. Aleong, Ricardo Alkmim Teixeira, Anthony A. Amato, Samuel J. Asirvatham, Yong‐Mei Cha, Domenico Corrado, Denis Duboc et al. · 2022 · Heart Rhythm
23. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy
    Todd Michael Rosenthal, Paul F. Stahls, FREDDY M. ABI‐SAMRA, Michael L. Bernard, Sammy Khatib, Glenn M. Polin, Joel Q. Xue, Daniel P. Morin · 2015 · Heart Rhythm
24. Benefit of Primary Prevention Implantable Cardioverter‐Defibrillators in the Setting of Chronic Kidney Disease: A Decision Model Analysis
    Mitesh S. Amin, Aaron D. Fox, Gautham Kalahasty, Richard K. Shepard, Mark A. Wood, Kenneth A. Ellenbogen · 2008 · Journal of Cardiovascular Electrophysiology
25. The New York Heart Association Classes and functional status: What are we really measuring?
    Claiborne Miller‐Davis, Sue Marden, Nancy Kline Leidy · 2006 · Heart & Lung
26. Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes
    Massimo Santini, Renato Pietro Ricci, Maurizio Lunati, Maurizio Landolina, Giovanni Battista Perego, Maurizio Marzegalli, Milena Schirru, Chiara Belvito, Roberto Brambilla, Giuseppe Guenzati et al. · 2008 · Journal of Interventional Cardiac Electrophysiology
27. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and the modelling of cost-effectivenessan cost-utility for these groups in a UK context
    Martin J Buxton, Noreen Caine, Daniela Patricia Chase, Derek T. Connelly, Andrew A. Grace, C Jackson, Julie Parkes, Linda D. Sharples · 2006 · Health Technology Assessment
28. Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device
    Kevin J. Clerkin, Veli Kemal Topkara, Ryan T. Demmer, Jose M. Dizon, melana yuzefpolskaya, J. Fried, Xingchen Mai, DONNA M. MANCINI, Koji Takeda, Hiroo Takayama et al. · 2017 · JACC Heart Failure
29. Heart failure as a substrate and trigger for ventricular tachycardia
    Chikezie Alvarez, Edmond M. Cronin, William L. Baker, Jeffrey Kluger · 2019 · Journal of Interventional Cardiac Electrophysiology
30. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004
    Sana M. Al‐Khatib, Gillian D Sanders, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy, J. Thomas Bigger, Alfred E. Buxton, Stuart J. Connolly, Alan Howard Kadish, Arthur J. Moss et al. · 2005 · American Heart Journal
31. Atrial pacing or ventricular backup–only pacing in implantable cardioverter-defibrillator patients
    Michael O. Sweeney, Kenneth A. Ellenbogen, ANTHONY S.L. TANG, David J. Whellan, Peter Thomas Mortensen, Francesco Giraldi, David A. Sandler, Lou Sherfesee, Todd Sheldon · 2010 · Heart Rhythm
32. Risk Assessment for Sudden Cardiac Death in Dialysis Patients
    Palaniappan Saravanan, Neil C. Davidson · 2010 · Circulation Arrhythmia and Electrophysiology
33. Non-Gaussian heart rate as an independent predictor of mortality in patients with chronic heart failure
    Ken Kiyono, Junichiro Hayano, Eiichi Watanabe, Zbigniew R. Struzik, Yoshiharu Yamamoto · 2007 · Heart Rhythm
34. Gender, Racial, and Health Insurance Differences in the Trend of Implantable Cardioverter‐Defibrillator ( ICD ) Utilization: A United States Experience Over the Last Decade
    Nileshkumar Patel, Sushruth Edla, Abhishek J. Deshmukh, Nikhil Nalluri, Nilay Patel, Kanishk Agnihotri, Nish Patel, Chirag Savani, Nish Patel, Ronak Bhimani et al. · 2016 · Clinical Cardiology
35. Up digital and personal: How heart digital twins can transform heart patient care
    Natalia A. Trayanova, Adityo Prakosa · 2023 · Heart Rhythm
36. A Systematic Review of the Association between Obstructive Sleep Apnea and Ventricular Arrhythmias
    Akhil Raghuram, Ryan Clay, Anusha Kumbam, Larisa G. Tereshchenko, Akram Khan · 2014 · Journal of Clinical Sleep Medicine
37. Current Status of Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter Defibrillator in Patients With Chronic Heart Failure
    Hiroyuki Satake, Koji Fukuda, Yasuhiko Sakata, Satoshi Miyata, Makoto Nakano, Masateru Kondo, Yuhi Hasebe, Masato Segawa, Hiroaki Shimokawa, on behalf of the CHART-2 Investigators · 2014 · Circulation Journal
38. Structure and function of coagulogen, a clottable protein in horseshoe crabs
    Tsukasa Osaki, S Kawabata · 2004 · Cellular and Molecular Life Sciences
39. Sudden Death Prior to Pediatric Heart Transplantation: Would Implantable Defibrillators Improve Outcome?
    Edward K. Rhee, Charles E. Canter, Susan Basile, Steven A. Webber, David C. Naftel · 2007 · The Journal of Heart and Lung Transplantation
40. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients
    Jens Brock Johansen, Susanne S. Pedersen, Helle Spindler, K. Andersen, Jens Cosedis Nielsen, Peter Thomas Mortensen · 2008 · EP Europace
41. Feasibility and clinical decision-making with 3D echocardiography in routine practice
    James Hare, Carly Jenkins, Satoshi Nakatani, Atsushi Ogawa, CM Yu, Thomas Hugh Marwick · 2007 · Heart
42. Optimal Programming of Implantable Cardiac-Defibrillators
    Malini Madhavan, Paul A. Friedman · 2013 · Circulation
43. Autonomic Regulation Therapy for the Improvement of Left Ventricular Function and Heart Failure Symptoms: The ANTHEM-HF Study
    Lorenzo A. DiCarlo, Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Inder S. Anand · 2013 · Journal of Cardiac Failure
44. Quantification of left ventricular indices from SSFP cine imaging: Impact of real‐world variability in analysis methodology and utility of geometric modeling
    Chris Miller, Peter Jordan, Alex Borg, Rachel Argyle, David Clark, Keith Pearce, Matthias Schmitt · 2012 · Journal of Magnetic Resonance Imaging
45. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker
    Andreas Schuchert, Carmine Muto, Themistoklis Maounis, Robert Frank, Eric Boulogne, Alexander Polauck, Luigi Padeletti, for the MASCOT study group · 2012 · EP Europace
46. Understanding Heart Failure
    Jeremy Aryeh Mazurek, Mariell L Jessup · 2016 · Heart Failure Clinics
47. The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization
    Gordon Willy Pak Ling Moe, Justin Adrian Ezekowitz, Eileen O’Meara, Jonathan G. Howlett, Stephen Edward Fremes, Abdul Al‐Hesayen, George A. Heckman, Anique Ducharme, Estrellita Estrella-Holder, Adam Grzeslo et al. · 2013 · Canadian Journal of Cardiology
48. Enfermedad cardiovascular en el anciano
    Charles F. Jackson, NANETTE KASS WENGER · 2011 · Revista Española de Cardiología
49. Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure
    Adrian F. Hernandez, Gregg C. Fonarow, Bradley G. Hammill, Sana M. Al‐Khatib, Clyde W. Yancy, Christopher M. O’Connor, Kevin Alan Schulman, Eric David Peterson, Lesley H. Curtis · 2009 · Circulation Heart Failure
50. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction
    Steven J. Keteyian, Debra Isaac, Udho Thadani, Brad A. Roy, Daniel Bensimhon, Robert Samuel McKelvie, Stuart D. Russell, Anne S. Hellkamp, William E. Kraus · 2009 · American Heart Journal
51. Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction
    Daniel P. Morin, Mawadda Saad, Omar F. Shams, J. S. Owen, J. Q. Xue, FREDDY M. ABI‐SAMRA, S. Khatib, Onajefe S Nelson-Twakor, Richard V. Milani · 2012 · EP Europace
52. Methods used for the assessment of LV systolic function: common currency or tower of Babel?
    Thomas Hugh Marwick · 2013 · Heart
53. Cardiac Sarcoidosis: Electrophysiological Outcomes on Long‐Term Follow‐Up and the Role of the Implantable Cardioverter‐Defibrillator
    Amr Mohsen, Alejandro Jiménez, ROBERT E. HOOD, Timm Michael Dickfeld, ANASTASIOS P. SALIARIS, Stephen Ross Shorofsky, MAGDI M. SABA · 2013 · Journal of Cardiovascular Electrophysiology
54. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT
    N. Sood, Anne‐Christine Ruwald, Scott David Solomon, James P. Daubert, Scott A McNitt, Bronislava Polonsky, Christian Jøns, C. A. Clyne, Wojciech Zaręba, Arthur J. Moss · 2013 · European Heart Journal
55. Safety considerations in the pharmacological management of atrial fibrillation
    A. John Camm · 2008 · International Journal of Cardiology
56. Quality of Life in Patients with an Implantable Cardioverter Defibrillator: A Systematic Review
    Juliane Tomzik, Katharina C. Koltermann, Markus Zabel, Stefan N. Willich, Thomas Reinhold · 2015 · Frontiers in Cardiovascular Medicine
57. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device
    Ayhan Yoruk, Saadia Sherazi, Howard Todd Massey, Valentina Kutyifa, Scott A McNitt, William Hallinan, David Tsu-Chau Huang, Leway Chen, Mehmet K. Aktaş · 2016 · Heart Rhythm
58. Electrical storm
    Dongsheng Gao, John L. Sapp · 2012 · Current Opinion in Cardiology
59. Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate
    Sérgio Barra, Serge Bovéda, Rui Andre Providencia, Nicolas Sadoul, Rudolf Martin Duehmke, Christian Reitan, Rasmus Borgquist, Kumar Narayanan, Françoise Hidden‐Lucet, Didier Klug et al. · 2017 · Journal of the American College of Cardiology
60. Cardiac autonomic imaging with SPECT tracers
    Mark I. Travin · 2012 · Journal of Nuclear Cardiology
61. No benefit of a dual coil over a single coil ICD lead: Evidence from the Sudden Cardiac Death in Heart Failure Trial
    Pierre S. Aoukar, Jeanne E. Poole, George William Johnson, Jill Anderson, Anne S. Hellkamp, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy · 2013 · Heart Rhythm
62. QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study
    Daniel P. Morin, Lasse Oikarinen, Matti T. Viitasalo, L. Toivonen, Markku S. Nieminen, SE Kjeldsen, Björn Dahlöf, M. John, Richard B. Devereux, Peter M. Okin · 2009 · European Heart Journal
63. Time‐Dependence of Appropriate Implantable Defibrillator Therapy in Patients with Ischemic Cardiomyopathy
    Alawi A.A. Alsheikh-Ali, MICHAEL HOMER, Prasad V. Maddukuri, Benjamin M. Kalsmith, N.A. Mark Estes, Mark S. Link · 2008 · Journal of Cardiovascular Electrophysiology
64. Sudden cardiac death in Chagas' heart disease in the contemporary era
    Reinaldo B. Bestetti, Augusto Cardinalli-Neto · 2008 · International Journal of Cardiology
65. Cost-Effectiveness of a Microvolt T-Wave Alternans Screening Strategy for Implantable Cardioverter-Defibrillator Placement in the MADIT-II–Eligible Population
    Paul S. Chan, Kenneth M. Steín, Theodore Chow, Mark Fendrick, J. Thomas Bigger, Sandeep S. Vijan · 2006 · Journal of the American College of Cardiology
66. Sudden Death in Hemodialysis: An Update
    Mehmet Kanbay, Barış Afşar, David J.A. Goldsmith, Adrian Constantin Covic · 2010 · Blood Purification
67. Rapid-Rate Nonsustained Ventricular Tachycardia Found on Implantable Cardioverter-Defibrillator Interrogation
    Jay Chen, George William Johnson, Anne S. Hellkamp, Jill Anderson, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy, Jeanne E. Poole · 2013 · Journal of the American College of Cardiology
68. Pulmonary Artery Pressure-Guided Heart Failure Management: US Cost-Effectiveness Analyses Using the Results of The CHAMPION Clinical Trial
    Melissa Martinson, Rupinder Bharmi, Nirav Dalal, William T. Abraham, Philip B. Adamson · 2016 · European Journal of Heart Failure
69. Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.
    Anthony Tang, Heather Joan Ross, Christopher S. Simpson, L. Brent Mitchell, Paul Dorian, Ron A. Goeree, Barry Hoffmaster, Malcolm Arnold, Mario R. Talajic · 2005 · PubMed
70. Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction
    Sean D. Pokorney, Amy Leigh Miller, Anita Y. Chen, Laine Elliott Thomas, Gregg C. Fonarow, James A. de Lemos, Sana M. Al‐Khatib, Eric David Peterson, Tracy Y. Wang · 2015 · JAMA
71. Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes
    Kristen Sullivan, Barbara Stella Doumouras, Bernadet T. Santema, Mary Norine Walsh, Pamela S. Douglas, Adriaan A. Voors, Harriette G.C. Van Spall · 2020 · Canadian Journal of Cardiology
72. Appropriate Evaluation and Treatment of Heart Failure Patients After Implantable Cardioverter-Defibrillator Discharge
    Joseph D. Mishkin, Sherry J. Saxonhouse, Gregory W. Woo, Thomas Adam Burkart, William M. Miles, JAMIE BETH CONTI, Richard S. Schofield, Samuel F. Sears, Juan M. Aranda · 2009 · Journal of the American College of Cardiology
73. Animal models of insulin resistance and heart failure
    Mauricio Velez, Smita Kohli, Hani N. Sabbah · 2013 · Heart Failure Reviews
74. Predictive Value of Microvolt T-Wave Alternans in Patients With Left Ventricular Dysfunction
    Daniel J. Cantillon, Kenneth M. Steín, Steven M. Markowitz, Suneet Mittal, Bindi K. Shah, Daniel P. Morin, Eran S. Zacks, Matthew James Janik, Shaun Ageno, Andreas C. Mauer et al. · 2007 · Journal of the American College of Cardiology
75. Real World Evaluation of Dual-Zone ICD and CRT-D Programming Compared to Single-Zone Programming: The ALTITUDE REDUCES Study
    Francis Roosevelt Gilliam, David L. Hayes, JOHN P. BOEHMER, JOHN DAY, Paul A. Heidenreich, Milan Seth, Paul W. Jones, Kenneth M. Steín, Leslie A. Saxon · 2011 · Journal of Cardiovascular Electrophysiology
76. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy
    Christine M. Albert, Rebecca J. Quigg, Samir Saba, N.A. Mark Estes, Andi Schaecter, Haris P. Subacius, Adam Howard, Joseph H. Levine, Alan Howard Kadish · 2008 · American Heart Journal
77. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: Primary results of the Rhythm ID Going Head to Head Trial
    Michael Robert Gold, Saleem Ahmad, Kevin F. Browne, Kellie Chase Berg, Lisa Thackeray, Ronald David Berger · 2011 · Heart Rhythm
78. Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging and the Risk of Sudden Cardiac Death in Patients With Coronary Disease and Left Ventricular Ejection Fraction >35%
    Jonathan Paul Piccini, Aijing Z. Starr, John R. Horton, Linda K. Shaw, Kerry L. Lee, Sana M. Al‐Khatib, Ami E. Iskandrian, Christopher M. O’Connor, Salvador Borges‐Neto · 2010 · Journal of the American College of Cardiology
79. Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective
    Paul Khairy · 2007 · Nature Clinical Practice Cardiovascular Medicine
80. Alternative strategies in arrhythmia therapy: Evaluation of Na/Ca exchange as an anti-arrhythmic target
    Gudrun Antoons, Rik Willems, Karin R. Sipido · 2011 · Pharmacology & Therapeutics
81. Physicians' Preferences and Attitudes About End-of-Life Care in Patients With an Implantable Cardioverter-Defibrillator
    Saadia Sherazi, James P. Daubert, Robert Block, Vinodh Jeevanantham, K. Abdelgadir, Michael R. DiSalle, James M. Haley, Abrar H. Shah · 2008 · Mayo Clinic Proceedings
82. The causes, consequences, and treatment of left or right heart failure
    Jesús Peteiro, Jesús Peteiro-Vázquez, Ana Gacía-Campos, Lourdes García‐Bueno, Juan Pablo Abugattás-de-Torres, Alfonso Castro‐Beiras · 2011 · Vascular Health and Risk Management
83. Adverse Interaction Between a Left Ventricular Assist Device and an Implantable Cardioverter Defibrillator
    Jennifer Ann Cowger, DAPHNE BETLEY, Fred Morady, Frank Pelosi · 2007 · Journal of Cardiovascular Electrophysiology
84. Does the heart transplant have a future?
    Matthias Fuchs, David Schibilsky, Wolfgang Zeh, Michael Berchtold‐Herz, Friedhelm Beyersdorf, Matthias Siepe · 2019 · European Journal of Cardio-Thoracic Surgery
85. Cardiovascular Disease in Women
    Stock, Eveline Oestreicher, Redberg, Rita · 2012 · Current Problems in Cardiology
86. Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French Registry
    Rui Andre Providencia, Éloi Marijon, Pier David Lambiase, Abdeslam Bouzeman, Pascal Defaye, Didier Klug, Denis Amet, Marie‐Cécile Perier, Daniel Gras, Vincent Algalarrondo et al. · 2016 · Journal of the American Heart Association
87. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study
    Axel Bauer, Mathias Klemm, Konstantinos D. Rizas, Wolfgang Hamm, Lukas von Stülpnagel, Michael Dommasch, Alexander Steger, Andrezej Lubinski, Panagiota Flevari, Markus Harden et al. · 2019 · The Lancet
88. The value of C‐reactive protein‐to‐albumin ratio in predicting long‐term mortality among HFrEF patients with implantable cardiac defibrillators
    Göksel Çinier, Mert İlker Hayıroğlu, Zeynep Kolak, Ozan Tezen, Ahmet Çağdaş Yumurtaş, Levent Pay, Semih Eren, Tuğba Çetin, Kazım Serhan Özcan, Ceyhan Türkkan et al. · 2021 · European Journal of Clinical Investigation
89. Machine learning in sudden cardiac death risk prediction: a systematic review
    Joseph Barker, Xin Li, Sarah Khavandi, David Koeckerling, Akash Kamalakshan Mavilakandy, Coral Pepper, Vassiliki Bountziouka, Long Chen, Ahmed I. Kotb, Ibrahim Antoun et al. · 2022 · EP Europace
90. Mechanisms and potential therapeutic targets for ventricular arrhythmias associated with impaired cardiac calcium cycling
    Kenneth R. Laurita, DAVID S. ROSENBAUM · 2007 · Journal of Molecular and Cellular Cardiology
91. Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection
    Derek V. Exner, DAVID H. BIRNIE, Gordon Willy Pak Ling Moe, Bernard Thibault, François Philippon, Jeff S. Healey, ANTHONY S.L. TANG, Éric Larose, Ratika Parkash · 2013 · Canadian Journal of Cardiology
92. Short-term variability of repolarization predicts ventricular tachycardia and sudden cardiac death in patients with structural heart disease: A comparison with QT variability index
    Peter Oosterhoff, Larisa G. Tereshchenko, Marcel A. G. van der Heyden, Raja N. Ghanem, Barry J. Fetics, Ronald David Berger, Marc A. Vos · 2011 · Heart Rhythm
93. Gender Differences in Anxiety and Concerns about the Cardioverter Defibrillator
    Helle Spindler, Jens Brock Johansen, Kirsten Andersen, Peter Thomas Mortensen, Susanne S. Pedersen · 2009 · Pacing and Clinical Electrophysiology
94. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death
    Malini Madhavan, Jonathan W. Waks, Paul A. Friedman, Daniel Bruce Kramer, Alfred E. Buxton, Peter A. Noseworthy, Ramila A. Mehta, David O. Hodge, Angela Y. Higgins, Tracy L. Webster et al. · 2016 · Circulation Arrhythmia and Electrophysiology
95. Entropy as a Novel Measure of Myocardial Tissue Heterogeneity for Prediction of Ventricular Arrhythmias and Mortality in Post-Infarct Patients
    Alexander F.A. Androulakis, Katja Zeppenfeld, Elisabeth H.M. Paiman, Sebastiaan R.D. Piers, Adrianus P. Wijnmaalen, Hans‐Marc J. Siebelink, Marek Šramko, Hildo J. Lamb, Rob J. van der Geest, Marta Riva et al. · 2019 · JACC. Clinical electrophysiology
96. Left Ventricular Mechanical Assist Devices and Cardiac Device Interactions: An Observational Case Series
    David Chee Guan Foo, BRUCE D. WALKER, Dennis L. Kuchar, Charles W. Thorburn, A. Tay, Chris Hayward, Peter Simon Macdonald, ANNE M. KEOGH, Eugene Kotlyar, Philip Spratt et al. · 2009 · Pacing and Clinical Electrophysiology
97. Serum Markers of Collagen Turnover Predict Future Shocks in Implantable Cardioverter-Defibrillator Recipients With Dilated Cardiomyopathy on Optimal Treatment
    EMMANUEL M. KANOUPAKIS, Emmanuel G. Manios, Eleftherios M. Kallergis, Hercules E. Mavrakis, Christos A. Goudis, Ilias G. Saloustros, Maria E. Milathianaki, GREGORY I. CHLOUVERAKIS, Panos E. Vardas · 2010 · Journal of the American College of Cardiology
98. A 15-Year Experience With Permanent Pacemaker and Defibrillator Lead and Patch Extractions
    Alexander Rusanov, Henry M. Spotnitz · 2009 · The Annals of Thoracic Surgery
99. Improving Survival Rates of Patients With Idiopathic Dilated Cardiomyopathy in Tuscany Over 3 Decades
    Gabriele Castelli, Alessandra Fornaro, Mauro Ciaccheri, Alberto Dolara, Vito Troiani, Benedetta Tomberli, Iacopo Olivotto, Gian Franco Gensini · 2013 · Circulation Heart Failure
100. Prognostic Impact of Familial Screening in Dilated Cardiomyopathy
     Michèle Moretti, Marco Merlo, Giulia Barbati, Andrea Di Lenarda, Francesca Brun, Bruno Pinamonti, Darío Gregori, Luisa Mestroni, Gianfranco Sinagra · 2010 · European Journal of Heart Failure